Moscow, Russia

Vsevolod I Ogarkov

This inventor holds 1 USPTO granted patent. Top assignee: Vsesojuzny Nauchno-Issledovatelsky Institut Genetiki. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vsevolod I Ogarkov. Retrieved from https://idiyas.com/inventor/vsevolod-i-ogarkov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vsevolod I Ogarkov: Innovator in Biotechnology

Introduction

Vsevolod I Ogarkov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the production of human leukocyte interferon alpha-2. His innovative methods have implications for medical research and treatment.

Latest Patents

Ogarkov holds a patent for a method of producing human leukocyte interferon alpha-2. This method involves submerged cultivation of a producer strain, Pseudomonas species VG-84, which carries a plasmid with the inserted gene of human leukocyte interferon alpha-2. The strain is cultivated in a nutrient medium containing sources of carbon and nitrogen, mineral salts, and growth stimulants, under aeration and in the presence of antibiotics. The process concludes with the isolation and purification of the end product. He has 1 patent to his name.

Career Highlights

Ogarkov is associated with the Vsesoyuzny Nauchno-Issledovatelsky Institut Genetiki, where he has been involved in groundbreaking research. His work has contributed to advancements in genetic engineering and biotechnology.

Collaborations

Some of his notable coworkers include Jury I Kozlov and Alexandr Y Strongin. Their collaborative efforts have furthered research in the field and have led to significant scientific advancements.

Conclusion

Vsevolod I Ogarkov's contributions to biotechnology, particularly through his patented method for producing human leukocyte interferon alpha-2, highlight his role as an innovator in the field. His work continues to influence medical research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…